Lauromacrogol
PreclinicalSmall molecule
Lauromacrogol is one of 4 small molecule programs targeting Gastric Varices. It is currently in Preclinical.
1
Indications
5
Total Trials
0
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
3 competitors in Gastric Varices
#DrugCompanyPhaseTrials
1Inderal
WWyeth-Lederle Vaccines
Approved
Octreotide
Johnson & JohnsonPreclinical
Ceradon
TakedaPreclinical
Lauromacrogol
WWest China Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Prophylaxis2 trials
Gastric Varices1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Lauromacrogol. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- WWest China Hospital